chrisvoncsefalvay/vaers-outcomes huggingface dataset:
The immediate reaction was severe pain in neck, knees, hand, ankles, nausea and fatigue. This occurred for 3 days then on Sunday I was admitted to the hospital. I was given pain medication discharged still exp tiredness and fatigue. The nausea was gradually going away started to loose all functions in hands. As of today my energy level is at at 75% my left hand is better and right hand still experiencing some numbness. I have seen a Neurologist, Rheumatologist and Cardiologist.
1/5 slight fatigue 5:30 am and sore arm 1/6 I took ibuprofen  but still had pain 1/8 I felt pain in arm pit  but it got a little 1/9 pain progressed to arm pit 1/10 pain still under arm and tender 1/11 My arm is sore with bump on injection site, warm to touch and painful.
nasal congestion, runny nose, tactile fever, body aches, chills, decreased taste, decreased smell, fatigue with positive PCR on 08/04/2021
pain in jaw; sensation of the vaccine go up my neck; TINGLING IN CHIN; This spontaneous case was reported by an other health care professional (subsequently medically confirmed) and describes the occurrence of PAIN IN JAW (pain in jaw), MUSCULOSKELETAL DISCOMFORT (sensation of the vaccine go up my neck) and PARAESTHESIA (TINGLING IN CHIN) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination.     Concurrent medical conditions included Bone graft.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to at an unspecified dose. On an unknown date, the patient experienced PAIN IN JAW (pain in jaw), MUSCULOSKELETAL DISCOMFORT (sensation of the vaccine go up my neck) and PARAESTHESIA (TINGLING IN CHIN). At the time of the report, PAIN IN JAW (pain in jaw), MUSCULOSKELETAL DISCOMFORT (sensation of the vaccine go up my neck) and PARAESTHESIA (TINGLING IN CHIN) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Most recent FOLLOW-UP information incorporated above includes: On 23-Apr-2021: No specific follow-up information recorded.
Patient passed out for a couple of seconds after the flu injection. He was sitting in a chair and did not sustain any further injury. He was evaluated by the provider and was cleared to leave the clinic.
Narrative: COVID infection following COVID vaccine series 02/09, Pfizer, dose #11 03/02, Pfizer, dose #2 09/15 COVID swab, result: detected 09/07pt cc: cough, fatigue, myalgias, nausea, rhinorrhea, headache exposure: unknown 09/21 clinically resolved
Pt was receiving her 2nd dose of the Pfizer vaccine. Prepped area per protocol and injected the needle into her right deltoid.  Approximately 0.1 dose was administered and then the needle would not inject any further vaccine even after Pharmacist pushed plunger. Pharmacist believes it was a misfunction of the needle.  Supervisor was immediately called and instructed Pharmacist to administer an additional dose per protocol. Pt was agreeable and Pharmacist  administered additional dose in patient's left deltoid without incident. Pharmacist stayed with patient for the 15 min monitoring period and patient felt fine after the 15 min monitoring period.
Had varicella vaccine administered on 4/12/05. On 4/23/05 began to notice redness 1 1/2" x 1 3/4" to L arm with itching. Benadryl given x 1 dose. No other symptoms.
A 27 year old male reported a " negative reaction after injection", a painful and swollen arm. Pt did not want to take any more injections. He was shortly afterwards terminated from employment due to repeatedly positive testing for illicit drug use and has been lost to follow up.
Sick; This is a spontaneous report from a non-contactable healthcare professional reporting similar events for six  patients. This report is for the fourth of the six patients. A patient of an unspecified age and gender received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE lot number/expiration date: not provided), via an unspecified route of administration, on an unspecified date (reported as "as recently as 20Jan2021"), as a single dose for COVID-19 vaccination. Relevant medical history was not reported. Historical vaccinations included the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE lot number/expiration date unknown) on an unspecified date. Concomitant medication were not reported. On an unknown date, the patient was sick. The outcome of the event sick was unknown.  No follow-up attempts are possible, information about lot/batch number cannot be obtained.  .; Sender's Comments: Linked Report(s) : US-PFIZER INC- 2021076551 Same drug and event, different patient;US-PFIZER INC- 2021076656 Same drug and event, different patient;US-PFIZER INC- 2021076655 Same drug and event, different patient;US-PFIZER INC- 2021076652 Same drug and event, different patient;US-PFIZER INC-2021076653 Same drug and event, different patient
This case was reported by a healthcare professional and described the occurrence of radiating pain in arm in a 46-year-old female subject who was vaccinated with ENGERIX B (GlaxoSmithKline). The subject's medical history included hypertension. Concurrent medical conditions included latex allergy. On 12 August 2008 at 15:00 the subject received 1st dose of ENGERIX B at 20 mcg in the right arm. On 12 August 2008, immediately after vaccination with ENGERIX B, the subject experienced pain in her arm that radiated up to her shoulder and neck. This pain resulted in a less than 30 percent range of motion in the arm that received the vaccine also with an onset of 12 August 2008. The following day, on 13 August 2008, the subject developed injection site discoloration (black and blue mark at injection site) which resolved on an unknown date. The subject additionally developed a facial rash on an unspecified date for which she has seen two dermatologist, but not her primary care physician. The rash was reported as resolved with no date provided. The radiating pain and decreased range of motion were reportedly worse at the time of reporting. The healthcare professional considered the events were disabling.
On 10/27/21 I received my Covid booster shot at a local Hospital. It was a Moderna booster. I had never experienced any type of ringing in my ears in my lifetime; but 2 nights later I was awakened by a tremendous ringing in my left ear.  It was as if a fire alarm was going off in my ear.  It subsided after 3-4 days and went away.  About a week later the ringing came back and I've experienced it constantly since then. Sometimes in one ear or the other, and sometimes in both. I haven't gone to the doctor about it. I'm hoping it goes away by itself.
Approximately hours after vaccine administered, deltoid area left arm began to become painful, swollen, and warm to touch. Patient applied ice and took Motrin. She repeated this and around 15 hours post immunization, area began to be less painful. THe discharge summary received on 3/3/04 states cellulitis and allergic reaction.
Developed  hives  hours later in the evening following administration. patient took 25 mg Benadryl  at time of eruption . Reported no difficulty breathing.Treated next day by urgent care with prednisone 20mg x 5 days.
My normally typical menstrual cycle (25-28 days)  has significantly changed since getting these two vaccines. I have an app that I've been logging my cycle in for years to compare. Here is a record of what I've experienced, with three periods in the month of September: August 21 (22 day cycle) bleeding lingered for two weeks September 6 (16 day cycle) September 16 (10 day cycle) September 25 (9 day cycle) October 7 (12 day cycle) October 17 (10 day cycle)
This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient. A 52-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 24Mar2021 at 13:30 as dose 1, single (Lot number: ER2613), in left arm, on 16Apr2021 at 13:30 as dose 2, single (Lot number: EW0150), in left arm and on 01Dec2021 at 13:30 as dose 3 (booster), single (Lot number: FG3527) at the age of 51 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "known allergies: Penicillin" (unspecified if ongoing), notes: known allergies: Penicillin. The patient's concomitant medications were not reported. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset Jun2022, outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (2022) Negative, notes: for 5 days; (Jul2022) positive, notes: (different brand); (Jul2022) Positive. Therapeutic measures were taken as a result of vaccination failure, covid-19. Additional information: After finishing the 5-day course of Paxlovid, the patient was tested negative for 5 days. 8 days after completing Paxlovid, the patient began to feel congestion in my head again, same as he did when he first contracted COVID. The patient originally thought it was allergies but the congestion worsened over the next 36 hours so out of caution, The patient took a rapid test that came back positive. The patient took another rapid test (different brand) to be sure, and that came back positive as well. No follow-up attempts are possible. No further information is expected.
Moderna COVID-19 Vaccine EUA: Vaccine recipient reported right sided facial tingling and numbness. Did not seek treatment.
935 AM walked in on porch next thing I'm on the floor hit my head on the cement floor my left knee was bleeding my hands were numb from hitting the floor. It took ten minutes or so before I could crawl to step to sit up and a few more minutes before I got in the house to get help. Went to hospital arrived at 1245.
Patient developed urticarial reaction at MMRV injection site shortly after immunization. Area was indurated. Patient recovered with Benadryl. Information has been received from a physician concerning a 15 month old male with no medical history or allergies who on 22-MAY-2007 evening was vaccinated SC on left leg with a first dose of MMR II (Oka/Merck upgrade process) (Lot # 657534/0474U). Concomitant therapy on the same day included a IM first dose on left leg of HEPATITIS A virus vaccine inactivated (MSD) (Lot # 652293/0248U) and a IM third dose on left leg of INFANRIX (Lot # AC14B033AA). There was no illness at the time of vaccination. On 22-MAY-2007 evening the patient developed a local reaction and returned to the office couple of days after vaccination. Unspecified medical attention was sought. At the time of report, the patient had recovered. A product quality complain was not involved. Additional information has been received from the physician who stated that the patient developed urticarial reaction at the injection site shortly after vaccination. The are was described as indurated. The patient was treated with BENADRYL. At the time of report the patient had recovered. This is one of seversl reports received from the same source. No further information is available.
One hour after vaccine, sudden onset of left ear feeling plugged and severe anxiety that continued until evening.  Approximately 10-11 hours after vaccine, onset red heavy spotting (on day #18 of menstrual cycle).  Spotting continued until 12/24, when normal flow period occurred x 2 days.  Thereafter, scant daily brown spotting has occurred.  Feeling of plugged ear has slightly improved but is still present - question if due to post-auricular LAD that is much improved but still present.  Anxiety continued with intermit frequency and severity, including a panic attack on 12/24 (only 2nd of life & with this one without provoking event); anxiety now slowly improving every day.   Other expected vaccine side effects also occurred, including fatigue, LAD (as noted), sore arm on day of vaccine, very brief chills (day of vaccine, only lasting 5 minutes).
4 hours after injection patient developed swelling, pain, redness over IM site. Seen in clinic 8/24/07 with 7 inch x 6 inch erythematous, hot, swollen tender lesion over left quadriceps.
soreness in the arm; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A patient (no qualifiers provided) received BNT162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown) for COVID-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "soreness in the arm".  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
4th dose of DTaP was accidentally administered 1 month short of the ACIP recommended interval schedule for this vaccine. It was suppose to be administered 6 months after 3rd dose but was administered 5 months after. 3rd dose was administered on 08/24/2019. There was no reaction , patient tolerated well. We realized this occurred yesterday when our office received an "imms error report".
This spontaneous report was received from a other health professional referring to a patient of unknown age and gender. Pertinent Medical History/Drug Reactions/Allergies were not reported. On 27-JAN-2016 the patient was vaccinated with an expired dose of VAQTA (lot # K002831, expiration date: 15-JAN-2016) 1 ml, intramuscular. Concomitant medications were not reported. No adverse effects were reported. No further information was provided. Additional information has been requested (correspondence containing a request for additional information is scheduled.).
This spontaneous report was received from a State Immunization Official and refers to multiple patients (exact number unspecified) of unknown age and gender. The patients' concurrent conditions, drug reactions or allergies, concomitant therapies and medical histories were not provided. On multiple unspecified dates, the patients might have been vaccinated with improperly stored doses of VAQTA injection, lot # M015290 and expiration date 20-SEP-2017, lot # M017982 and expiration date 13-SEP-2017, lot # M022924 and expiration date 24-JAN-2018 (doses and routes of administration were not reported) for prophylaxis. Administered doses of vaccines experienced the temperature excursion of 29.3 degrees Fahrenheit (F) for 2 hours 56 minutes, 28.8 F for 7 hours 6 minutes, 34.7 F for 26 minutes, 34.5 F for 27 minutes, 33.6 F for 1 hour 13 minutes , 30.6 F for 5 hours 55 minutes, 31 F for 3 hours 30 minutes, 33 F for 1 hour 59 minutes, 33.4 F for 2 hours 20 minutes, 32 F for 4 hours 15 minutes, 32 F for 3 hours 52 minutes, 32 F for 4 hours 4 minutes, 30.1 F for 4 hours 53 minutes, 31.7 F for 4 hours 5 minutes, 32.5 F for 2 hours 21 minutes, 33.2 F for 2 hours 16 minutes and 33 F for 1 hour 23 minutes. Data logger was involved. There were no previous excursions reported. There was no adverse effect reported. Product quality complaint (PQC) was not involved. This is one of several reports received from the same reporter. Additional information has been requested.; Sender's Comments: US-009507513-1612USA009918: US-009507513-1612USA014168: US-009507513-1612USA014170:
Approximately five minutes after shot, my face began to tingle. My heart felt like it was racing. I had difficulty focusing with my eyes, it felt like my eyes were rolling.  My feet began to tingle. My spouse honked the car horn for assistance. I reached for my epi pen but did not administer it because a doctor was approaching our car. I checked my pulse rate on my iWatch, it was 168.  My throat began to feel tight. The doctor listened to my lungs and heard wheezing. A paramedic came over as well. My blood pressure was taken but I do not remember what my blood pressure was.  At that point the doctor said I should use my epi pen. The paramedic said I should use Benadryl. They were in disagreement, and the paramedic said I should take 50mg of Benadryl and had me put my car seat in recline position.  It was at the point they noticed that my face and chest were flushed.  They had me drink water.  We waited about 45 minutes. My lungs were checked again by the paramedic and I was told my lungs were clear, my blood pressure was taken second time but I do not remember my blood pressure, my face was less flush,  my pulse was in the 70?s.  I still felt tingling on my scalp and feet, my throat felt like it had a lump in it.  I Began to feel nauseous.  I was given the okay to leave and go home.  I had nausea until the evening the next day.  I did not eat until dinner time the night after my shot.  I only drank water.  The next day I experienced shortness of breath performing  duties that typically do not make me out of breath.  I had to take many breaks and used my abuterol inhaler two times.
77YO got Menveo prescription, Vx not given; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of intercepted drug prescribing error in a 77-year-old male patient who did not receive Men ACWY-CRM NVS (Menveo) for prophylaxis.   On an unknown date, the patient did not receive Menveo. On an unknown date, an unknown time after not receiving Menveo, the patient experienced intercepted drug prescribing error (Verbatim: 77YO got Menveo prescription, Vx not given). The outcome of the intercepted drug prescribing error was unknown.   Additional Information: GSK Receipt Date: 04-MAY-2023 The registered pharmacist reported that the 77 year old patient had a prescription for Menveo of 2 vial. Since it was out of the recommended age range, if any guidance the patient could get. No vaccine administered yet as of the call but patient has a prescription for Menveo. The reporter did not consent to follow up. The pharmacist intercepted the prescription error, which led to intercepted drug prescribing error.
Decrease in breastmilk supply. Was pumping 40oz of milk daily for the past several months, lost supply overnight. Baby was unsatisfied at the breast and pumping less than 20 oz of milk in a day. This lasted for approximately 3 days. After days of emptying breast 10+ times per day, supply started to resume to normal.
After administration of vaccine patient fainted. 911 was contacted and EMS responded, then transported patient for further care.
Breakthrough COVID 19 infection; Breakthrough COVID 19 infection; This is a spontaneous report received from a contactable reporter(s) (Pharmacist).  A 32-year-old male patient received BNT162b2 (BNT162B2), as dose 2, single (Batch/Lot number: unknown) and in Feb2022 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 32 years intramuscular, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history was not reported. No other vaccines within 4 weeks prior to the COVID vaccine. The patient had no COVID prior vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Facility type vaccine was Pharmacy or Drug Store. There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 31May2022, outcome "not recovered" and all described as "Breakthrough COVID 19 infection". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Unknown results. Therapeutic measures were not taken as a result of drug ineffective, covid-19.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Based on the information available and close temporal association, a possible contributory role of the suspect Product cannot be excluded for the reported events . The case will be reassessed once new information is available.
Pt came in today for Covid19 Pfizer 2nd dose vaccine. Vaccine was administered at 3:15pm and pt was advised to remain in exam room for 30 min post vaccine to monitor for reaction.  I checked on pt around 3:20pm to see how was she was doing and she reported arm felt really hot above injection site and that her face felt warm.  I at that time went and got provider FNP-C to assess pt.  Pt did not feel like throat was swelling or closing up at that time and states she felt fine other that face and arm being hot.  I continued to check in on pt every few minutes  to observe for reaction.  Around 3:30pm pt states she was now starting to itch across the upper part of her chest/neck and arms were also itching.  She also stated she now felt like throat may be swelling.  She also states she still feels very hot in her face. RN and myself contacted provider FNP-C who advised us to go ahead and administer Benadryl 50mg IM.  Benadryl 50mg was given IM right glute at 3:35pm and FNP-C came in to check on pt and start full assessment. FNP-C took over care for pt at that time.
Patient reports intermittent numbness and tingling to bilateral thumbs, index and middle fingers and palms.  Patient states symptoms started the same day as receiving her second dose, later in the day.  Patient unsure if she will seek further evaluation.
Information regarding PREVNAR was received from a consumer, who reported a friend's child, a female patient had received a full PREVNAR schedule and still got a pneumococcal illness. The patient received the fourth dose on an unspecified date. The patient received a "full PREVNAR schedule" (dates not specified) and "still got a pneumococcal illness" on an unspecified date. The patient's outcome was unknown. No further information was available at the time of this report.
2:02 pm Patient received Influenza vaccine 2:20 pm Patient complaining of itching and redness to right arm. 2:30 pm Patient assessed and seen in clinic by doctor. Diphenhydramine 50 mg/ml injection  0.5ml  IM x one dose today and Benadryl  25 mg one capsule every six hours as needed for itching prescribed. 3:38 pm  Diphenhydramine 50 mg/ml injection  0.5ml  IM x one dose given and patient observed for 15 minutes.
This spontaneous report as received from a nurse refers to multiple unspecified numbers of patient of unknown ages. On an unknown date the patients was vaccinated with VARIVAX (Merck) (dose unknown). No concomitant medications were reported. The nurse reported that the patients may have been administered VARIVAX (Merck) that went through an unsupported temperature excursion. Additional information has been requested.
Rt arm sore at injection site. Redness, swelling, difficulty in movement, pain and tenderness.
Patient stated to PCP that she developed significant weakness 2-5 days post second COVID vaccine. Pt also developed significant SOB. Pt is now unable to walk short distances and is  unable to lift her legs, gets lethargic easily, and uses a wheelchair.